...
首页> 外文期刊>RSC Advances >In vitro/in vivo study of novel anti-cancer, biodegradable cross-linked tannic acid for fabrication of 5-fluorouracil-targeting drug delivery nano-device based on a molecular imprinted polymer
【24h】

In vitro/in vivo study of novel anti-cancer, biodegradable cross-linked tannic acid for fabrication of 5-fluorouracil-targeting drug delivery nano-device based on a molecular imprinted polymer

机译:在体外/体内研究新型抗癌,可生物降解的交联单宁单宁酸的制备基于分子印迹聚合物的5-氟尿嘧啶靶向药物递送纳米装置

获取原文
获取原文并翻译 | 示例
           

摘要

Using biodegradable material in medicinal applications is known as an important factor. On the other hand, the delivery of drugs directly to the target site is a promising field of research especially for anti-cancer drug delivery systems. The present research aimed to evaluate an effective anti-cancer device for treatment of tumors. In this respect, a novel fluorescent multi core-shell structure of magnetic molecular imprinted polymer nanoparticles based on biodegradable materials was designed as a carrier for targeted, sustained and controlled release of 5-fluorouracil (5-FU). Herein, tannic acid as a biodegradable polyphenol with potential anti-cancer performance was used to fabricate a cross-linker agent. Then, a mini-emulsion polymerization technique was performed in the presence of magnetic fluorescent cores for preparing the carrier. The structure of samples was fully characterized using various kinds of analyses. Afterwards, the performance of the product as an anti-cancer carrier was examined through different in vivo and in vitro analyses including small animal body imaging, the MTT viability assay and high performance liquid chromatography (HPLC). The biodegradable structure of samples was also investigated in various environments similar to the human body. Furthermore, in vitro analyses on Michigan Cancer Foundation-7 (MCF-7) cells provided evidence for the multiple anti-cancer performances of the carrier. Based on the obtained results, this novel drug carrier with outstanding properties can perform an effective and obvious roll in the cancer-therapy field.
机译:使用药用应用中的可生物降解材料被称为重要因素。另一方面,直接向目标网站递送药物是一个有前途的研究领域,特别是对于抗癌药物递送系统。目前的研究旨在评估一种治疗肿瘤的有效抗癌装置。在这方面,基于可生物降解材料的磁性分子压印聚合物纳米颗粒的新型荧光多核 - 壳结构设计为靶向,持续和控制释放的5-氟尿嘧啶(5-FU)的载体。这里,使用具有潜在抗癌性能的可生物降解的多酚的鞣酸酸制造交联剂。然后,在用于制备载体的磁性荧光芯存在下进行微型乳液聚合技术。使用各种分析完全表征样品的结构。然后,通过不同的体内和体外分析检查产品作为抗癌载体的产品的性能,包括小动物体成像,MTT活力测定和高效液相色谱(HPLC)。还在类似于人体的各种环境中研究了样品的可生物降解结构。此外,在密歇根癌症基础-7(MCF-7)细胞上的体外分析为载体的多种抗癌性能提供了证据。基于所得的结果,这种具有出色性能的新型药物载体可以在癌症治疗领域进行有效和明显的卷。

著录项

  • 来源
    《RSC Advances》 |2016年第43期|共11页
  • 作者单位

    Amirkabir Univ Technol Dept Chem POB 15875-4413 Tehran Iran;

    Amirkabir Univ Technol Dept Chem POB 15875-4413 Tehran Iran;

    Univ Miami Dept Chem Coral Gables FL 33124 USA;

    Islamic Azad Univ Saveh Branch Young Researchers &

    Elite Club Saveh Iran;

    Univ Miami Dept Chem Coral Gables FL 33124 USA;

    Amirkabir Univ Technol Dept Chem POB 15875-4413 Tehran Iran;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号